Stockscreener 앱 받기
48.74
1.67%
0.80
시간 외 거래:
48.50
-0.24
-0.49%
Tg Therapeutics Inc 주식(TGTX)의 최신 뉴스
TGTX Stock Continues Rally For 8 Straight Sessions On New BRIUMVI Clinical Data - Stocktwits
TGTX Stock Hits Fresh 52-Week High – Here’s Why Retail Is Bullish Despite Q1 Earnings Miss - Stocktwits
US High Growth Tech Stocks To Watch: 3 Top Picks - Sahm
TGTX Stock Slips After Earnings – But CEO's $1B Briumvi Outlook Keeps Retail Bullish - Stocktwits
Trading Systems Reacting to (TGTX) Volatility - Stock Traders Daily
Bank of America Corp DE Purchases 610,195 Shares of TG Therapeutics, Inc. $TGTX - MarketBeat
Assenagon Asset Management S.A. Lowers Stock Position in TG Therapeutics, Inc. $TGTX - MarketBeat
TG Therapeutics, Inc. (TGTX) Stock Forecasts - Yahoo Finance
TG Therapeutics, Inc. (TGTX) Latest Stock News & Headlines - Yahoo Finance
TGTX Stock Rises On Wall Street Price Target Hike, New Schizophrenia Trial Launch - Stocktwits
Viking Therapeutics Declined in July, and why its Long-Term Prospects are Undiminished - AOL.com
TG Therapeutics, Inc. (TGTX) Stock Price, News, Quote & History - finance.yahoo.com
TG Therapeutics (TGTX) Q2 2026 Earnings Call Transcript - AOL.com
TG Therapeutics, Inc. (TGTX) Stock Analysis: A Biotech with Strong Revenue Growth and Substantial Upside Potential - DirectorsTalk Interviews
TG Therapeutics, Inc. $TGTX Position Trimmed by First Trust Advisors LP - MarketBeat
TG Therapeutics Inc (TGTX) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com
TG Therapeutics, Inc. (TGTX) Stock forecasts - Yahoo Finance UK
TG Therapeutics (TGTX) Is Down 7.4% After Q2 Profit Drop Despite Higher 2026 Revenue Guidance – Has The Bull Case Changed? - Sahm
TG Therapeutics, Inc. (NASDAQ:TGTX) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
TG Therapeutics Inc (TGTX) Stock News Today - TradingKey
Director gifts 6,050 TG Therapeutics (TGTX) shares to 501(c)(3) - Stock Titan
TGTX Maintained by JP Morgan -- Price Target Raised to $72.00 - GuruFocus
JPMorgan Chase & Co. Issues Positive Forecast for TG Therapeutics (NASDAQ:TGTX) Stock Price - marketbeat.com
TG Therapeutics (TGTX) Looks Fairly Valued After Raised 2026 Guidance And Mixed Q2 Earnings - simplywall.st
California State Teachers Retirement System Increases Stock Position in TG Therapeutics, Inc. $TGTX - MarketBeat
TG Therapeutics Earnings Call Signals BRIUMVI Surge - The Globe and Mail
TG Therapeutics 2026: Revenue $240.34M, EPS $0.05— 10-Q Summary - tradingview.com
TG Therapeutics (NASDAQ: TGTX) grows 2026 revenue to $445 million - Stock Titan
TG Therapeutics, Inc. $TGTX Shares Purchased by Sei Investments Co. - MarketBeat
Is TG Therapeutics (TGTX) A Bargain As Higher Guidance Meets A Sharp Pullback? - Yahoo Finance
TG Therapeutics, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
TG Therapeutics (TGTX) Stock May Be Undervalued As Revenue Guidance Rises - Yahoo Finance
TG Therapeutics (TGTX) Stock Sinks As Profit Shrinks Behind BRIUMVI Growth - Sahm
TG Therapeutics (TGTX) Is Down 15.9% After Q2 Miss But Raised 2026 OutlookWhat's Changed - finance.yahoo.com
TG Therapeutics: Why I'm Staying Long After The Q2 Selloff (NASDAQ:TGTX) - Seeking Alpha
Why TG Therapeutics (TGTX) Stock Is Down Today - Quiver Quantitative
TG Therapeutics (NASDAQ:TGTX) Trading Down 9% on Disappointing Earnings - MarketBeat
TG Therapeutics Reports Second Quarter 2026 Financial Results and Raises BRIUMVI® Revenue Guidance - TG Therapeutics
TG Therapeutics Q2 Earnings Call Highlights - MarketBeat
Earnings call transcript: TG Therapeutics Q2 2026 revenue rises, shares fall 5% - Investing.com
TG Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Here's What Key Metrics Tell Us About TG Therapeutics (TGTX) Q2 Earnings - Yahoo Finance
TG Therapeutics raises 2026 revenue guidance on Briumvi sales - Investing.com
TG Therapeutics Raises 2026 Outlook Following Strong Briumvi Sales Growth - Yahoo Finance
Weekly Recap: B. Riley raises TG Therapeutics target to $86 and Aug 3 Q2 call - TradingView
TG Therapeutics Q2 Earnings Fall, Revenue Rises; Fiscal 2026 Revenue Outlook Raised - Yahoo Finance
TG Therapeutics reports Q2 2026 revenue ~$240M, raises 2026 BRIUMVI U.S. revenue guidance - TradingView
TG Therapeutics: Q2 Earnings Snapshot - Barchart.com
TG Therapeutics (NASDAQ: TGTX) lifts 2026 BRIUMVI revenue outlook - Stock Titan
TG Therapeutics, Inc. (TGTX) Stock Analysis: 31.52% Potential Upside Beckons Investors - DirectorsTalk Interviews
How Tg Therapeutics Inc. (TGTX) Affects Rotational Strategy Timing - Stock Traders Daily
SummitTX Capital L.P. Sells 32,875 Shares of TG Therapeutics, Inc. $TGTX - MarketBeat
TG Therapeutics, Inc. Revenue Breakdown – NASDAQ:TGTX - TradingView
Edgestream Partners L.P. Buys Shares of 168,351 TG Therapeutics, Inc. $TGTX - MarketBeat
TG Therapeutics, Inc. Revenue Breakdown – MIL:1TGTX - TradingView
TG Therapeutics to Discuss 2026 Outlook on Aug. 3 Call - Stock Titan
TG Therapeutics Inc (TGTX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
TGTX|TG Therapeutics Inc|Price:55.760|Chg%:-0.280 - TradingKey
TGTX Maintains Buy Rating -- Price Target Raised to $86.00 by B. Riley Securities - GuruFocus
TG THERAPEUTICS INC : B. RILEY RAISES TARGET PRICE TO $86 FROM $55 - Bitget
0.52%
0.07%
자본화:
|
볼륨(24시간):